Roundup: Pfizer Finalizes ResApp Acquisition and More Briefings

Pfizer completes ResApp purchase for over $115 million

Biopharmaceutical giant Pfizer has completed the acquisition of ASX-listed digital health startup ResApp for AU$179 million (US$116 million), according to the University of Queensland. University of Queensland.

Brisbane-based ResApp has developed a mobile app that analyzes cough sounds and diagnoses respiratory ailments, including asthma, pneumonia, bronchiolitis, pneumonia and chronic obstructive pulmonary disease count. The company also recently demonstrated the app’s ability to diagnose COVID-19.

Approved for use in Australia and Europe, ResAppDx can be integrated with telehealth platforms, emergency departments and primary care settings.

New NHMRC-backed center to apply AI in breast cancer risk classification

A risk-based approach using AI will be applied to a newly launched breast cancer screening center at the University of Melbourne.

Supported by the National Health and Medical Research Council (NHMRC), Australia’s main regulator for medical research, the My Breast Cancer Risk Center (MyBRISK) will use AI to analyzed millions of mammogram images to identify “more robust mammogram-based risk factors.”

These automated measures, combined with family history, lifestyle and genetic testing, will allow the test to better classify women of all ages at their breast cancer risk, the university said. said in a media release.

Since current breast cancer risk assessment tools are said to be “clunky and imprecise,” the new NHMRC Center of Excellence aims to “create pathways to individualized screening.” become more efficient.”

MyBRISK is a partnership between the University of Melbourne, Melbourne’s St Vincent’s Hospital, Monash University, the University of Western Australia, Queensland University of Technology and the Cancer Council Victoria.

Digital tool to reduce medication errors in children’s hospitals: study

New research in Sydney has demonstrated how the use of electronic drug administration systems (eMeds) can help reduce medication errors in children’s hospitals.

Conducted by Macquarie University, Children’s Hospital Sydney and eHealth NSW, the study involved a review of more than 43,000 prescriptions for approximately 8,000 pediatric patients.

eMeds, currently used in 200 hospitals across New South Wales to prescribe, dispense and deliver medicines to patients, was developed by eHealth NSW. The technology also helps monitor interactions and dosages and issues safety warnings to avoid errors.

Townsville University Hospital deploys Dell data storage solutions

University Hospital Townsville (TUH), a university referral hospital in northern Queensland, has implemented data storage solutions from Dell Technologies to enhance information sharing and quality of care.

According to the press release, the hospital has adopted Dell PowerStore, a single storage platform that provides block-based storage and a centralized data lake. It has become the basis of patient flow reporting and ward management systems, leading to “significant growth” in clinical communication and allowing staff to perform near-real-time reporting instead. because of batch processing.

TUH also implements Dell PowerScale, which provides a single repository for unstructured data.

“Together, the new storage solutions provide TUH with additional performance, improved redundancy, scalability, and flexibility,” Dell said in a statement.

Source link


News7h: Update the world's latest breaking news online of the day, breaking news, politics, society today, international mainstream news .Updated news 24/7: Entertainment, the World everyday world. Hot news, images, video clips that are updated quickly and reliably

Related Articles

Back to top button